Publication | Open Access
A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
124
Citations
39
References
2011
Year
Pazopanib showed encouraging activity in heavily pretreated nasopharyngeal carcinoma with an acceptable toxicity profile.
| Year | Citations | |
|---|---|---|
Page 1
Page 1